Patterns and Predictors of First-Line Antiretroviral Therapy Modification in HIV-1-Infected Adults in a Large Urban Outpatient Cohort in Nigeria
Objective: We described the magnitude, type, and factors associated with first-line antiretroviral therapy (ART) modification in HIV-1-infected adults on ART in Jos, Nigeria. Method: Data on 6309 patients initiated on first-line ART between January 2004 and December 2006 were analyzed retrospectivel...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2015-07-01
|
Series: | Journal of the International Association of Providers of AIDS Care |
Online Access: | https://doi.org/10.1177/2325957414565508 |
id |
doaj-b9e602390faa42a985a976030a53bcf2 |
---|---|
record_format |
Article |
spelling |
doaj-b9e602390faa42a985a976030a53bcf22020-11-25T03:46:05ZengSAGE PublishingJournal of the International Association of Providers of AIDS Care2325-95742325-95822015-07-011410.1177/2325957414565508Patterns and Predictors of First-Line Antiretroviral Therapy Modification in HIV-1-Infected Adults in a Large Urban Outpatient Cohort in NigeriaIsaac Okoh Abah BPharm, MSc0Kristin M. Darin PharmD1Augustine Odo Ebonyi MBBS, MSc2Placcid Ugoagwu BSc3Victor Bazim Ojeh BPharm4Naima Nasir BPharm5Kakjing D. Falang BPharm MSc6Oluremi Olaitan BPharm, Msc7Oche Agbaji MBBS8John Idoko MBBS9Phyllis Kanki DVM, SD10 Jos University Teaching Hospital, Jos, Nigeria Feinberg School of Medicine, Northwestern University, Chicago, IL, USA University of Jos/Jos University Teaching Hospital, Jos, Nigeria Jos University Teaching Hospital, Jos, Nigeria Jos University Teaching Hospital, Jos, Nigeria Jos University Teaching Hospital, Jos, Nigeria University of Jos, Jos, Nigeria AIDS Prevention Initiative in Nigeria, Ltd./Gte, Lagos, Nigeria University of Jos/Jos University Teaching Hospital, Jos, Nigeria National Agency for the Control of AIDS (NACA), Abuja, Nigeria Harvard School of Public Health, Boston, MA, USAObjective: We described the magnitude, type, and factors associated with first-line antiretroviral therapy (ART) modification in HIV-1-infected adults on ART in Jos, Nigeria. Method: Data on 6309 patients initiated on first-line ART between January 2004 and December 2006 were analyzed retrospectively. Factors predictive of modification to initial ART were assessed by chi-square and multivariable logistic regression analysis. Results: Overall, 5212 (83%) included patients incurred a modification (73.3% drug substitution and 9.7% drug switch) to their initial first-line ARV regimen during a median (interquartile range) follow-up period of 7 (3-8) years. Drug substitutions of zidovudine (ZDV) were less likely than of tenofovir (TDF; adjusted odd ratio [AOR] 0.6; 95% confidence interval [CI]: 0.51-0.71), and Drug substitutions of efavirenz (EFV) were more likely than of nevirapine (NVP)-containing (AOR 1.82; 95% CI: 1.42-2.33) regimens. Predictors of switch to second-line regimen include older age (AOR 2.05; 95% CI: 1.68-2.51), CD4 count ≤100 cells/mm 3 (AOR 1.89; 95% CI: 1.49-2.37), EFV compared to NVP (AOR 1.38; 95% CI: 1.02-1.88), and drug toxicity (AOR 1.90; 95% CI: 1.48-2.43). Conclusion: Modification to initial ART was common in this study. Further evaluation of the contribution of guideline changes on regimen modification and treatment outcomes is recommended.https://doi.org/10.1177/2325957414565508 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Isaac Okoh Abah BPharm, MSc Kristin M. Darin PharmD Augustine Odo Ebonyi MBBS, MSc Placcid Ugoagwu BSc Victor Bazim Ojeh BPharm Naima Nasir BPharm Kakjing D. Falang BPharm MSc Oluremi Olaitan BPharm, Msc Oche Agbaji MBBS John Idoko MBBS Phyllis Kanki DVM, SD |
spellingShingle |
Isaac Okoh Abah BPharm, MSc Kristin M. Darin PharmD Augustine Odo Ebonyi MBBS, MSc Placcid Ugoagwu BSc Victor Bazim Ojeh BPharm Naima Nasir BPharm Kakjing D. Falang BPharm MSc Oluremi Olaitan BPharm, Msc Oche Agbaji MBBS John Idoko MBBS Phyllis Kanki DVM, SD Patterns and Predictors of First-Line Antiretroviral Therapy Modification in HIV-1-Infected Adults in a Large Urban Outpatient Cohort in Nigeria Journal of the International Association of Providers of AIDS Care |
author_facet |
Isaac Okoh Abah BPharm, MSc Kristin M. Darin PharmD Augustine Odo Ebonyi MBBS, MSc Placcid Ugoagwu BSc Victor Bazim Ojeh BPharm Naima Nasir BPharm Kakjing D. Falang BPharm MSc Oluremi Olaitan BPharm, Msc Oche Agbaji MBBS John Idoko MBBS Phyllis Kanki DVM, SD |
author_sort |
Isaac Okoh Abah BPharm, MSc |
title |
Patterns and Predictors of First-Line Antiretroviral Therapy Modification in HIV-1-Infected Adults in a Large Urban Outpatient Cohort in Nigeria |
title_short |
Patterns and Predictors of First-Line Antiretroviral Therapy Modification in HIV-1-Infected Adults in a Large Urban Outpatient Cohort in Nigeria |
title_full |
Patterns and Predictors of First-Line Antiretroviral Therapy Modification in HIV-1-Infected Adults in a Large Urban Outpatient Cohort in Nigeria |
title_fullStr |
Patterns and Predictors of First-Line Antiretroviral Therapy Modification in HIV-1-Infected Adults in a Large Urban Outpatient Cohort in Nigeria |
title_full_unstemmed |
Patterns and Predictors of First-Line Antiretroviral Therapy Modification in HIV-1-Infected Adults in a Large Urban Outpatient Cohort in Nigeria |
title_sort |
patterns and predictors of first-line antiretroviral therapy modification in hiv-1-infected adults in a large urban outpatient cohort in nigeria |
publisher |
SAGE Publishing |
series |
Journal of the International Association of Providers of AIDS Care |
issn |
2325-9574 2325-9582 |
publishDate |
2015-07-01 |
description |
Objective: We described the magnitude, type, and factors associated with first-line antiretroviral therapy (ART) modification in HIV-1-infected adults on ART in Jos, Nigeria. Method: Data on 6309 patients initiated on first-line ART between January 2004 and December 2006 were analyzed retrospectively. Factors predictive of modification to initial ART were assessed by chi-square and multivariable logistic regression analysis. Results: Overall, 5212 (83%) included patients incurred a modification (73.3% drug substitution and 9.7% drug switch) to their initial first-line ARV regimen during a median (interquartile range) follow-up period of 7 (3-8) years. Drug substitutions of zidovudine (ZDV) were less likely than of tenofovir (TDF; adjusted odd ratio [AOR] 0.6; 95% confidence interval [CI]: 0.51-0.71), and Drug substitutions of efavirenz (EFV) were more likely than of nevirapine (NVP)-containing (AOR 1.82; 95% CI: 1.42-2.33) regimens. Predictors of switch to second-line regimen include older age (AOR 2.05; 95% CI: 1.68-2.51), CD4 count ≤100 cells/mm 3 (AOR 1.89; 95% CI: 1.49-2.37), EFV compared to NVP (AOR 1.38; 95% CI: 1.02-1.88), and drug toxicity (AOR 1.90; 95% CI: 1.48-2.43). Conclusion: Modification to initial ART was common in this study. Further evaluation of the contribution of guideline changes on regimen modification and treatment outcomes is recommended. |
url |
https://doi.org/10.1177/2325957414565508 |
work_keys_str_mv |
AT isaacokohabahbpharmmsc patternsandpredictorsoffirstlineantiretroviraltherapymodificationinhiv1infectedadultsinalargeurbanoutpatientcohortinnigeria AT kristinmdarinpharmd patternsandpredictorsoffirstlineantiretroviraltherapymodificationinhiv1infectedadultsinalargeurbanoutpatientcohortinnigeria AT augustineodoebonyimbbsmsc patternsandpredictorsoffirstlineantiretroviraltherapymodificationinhiv1infectedadultsinalargeurbanoutpatientcohortinnigeria AT placcidugoagwubsc patternsandpredictorsoffirstlineantiretroviraltherapymodificationinhiv1infectedadultsinalargeurbanoutpatientcohortinnigeria AT victorbazimojehbpharm patternsandpredictorsoffirstlineantiretroviraltherapymodificationinhiv1infectedadultsinalargeurbanoutpatientcohortinnigeria AT naimanasirbpharm patternsandpredictorsoffirstlineantiretroviraltherapymodificationinhiv1infectedadultsinalargeurbanoutpatientcohortinnigeria AT kakjingdfalangbpharmmsc patternsandpredictorsoffirstlineantiretroviraltherapymodificationinhiv1infectedadultsinalargeurbanoutpatientcohortinnigeria AT oluremiolaitanbpharmmsc patternsandpredictorsoffirstlineantiretroviraltherapymodificationinhiv1infectedadultsinalargeurbanoutpatientcohortinnigeria AT ocheagbajimbbs patternsandpredictorsoffirstlineantiretroviraltherapymodificationinhiv1infectedadultsinalargeurbanoutpatientcohortinnigeria AT johnidokombbs patternsandpredictorsoffirstlineantiretroviraltherapymodificationinhiv1infectedadultsinalargeurbanoutpatientcohortinnigeria AT phylliskankidvmsd patternsandpredictorsoffirstlineantiretroviraltherapymodificationinhiv1infectedadultsinalargeurbanoutpatientcohortinnigeria |
_version_ |
1724507990472523776 |